Product Details
| Product Name: Erlotinib hydrochloride | CAS No.: 183319-69-9 |
| Min. Order: 1g | Purity: 99.0% |
| Supply Ability: 200kg/month | Release date: 2020/07/22 |
▼
▲
Prodcut name
Erlotinib hydrochloride
Synonyms
N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride; 6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride
MOQ
1G
CAS No.
183319-69-9
Appearance
White or off- white crystalline powder
Molecular Formula
C22H23N3O4.HCl
Molecular Weight
429.90
Assay
99%
Application
Pharma grade or research purpose
Packing
As per your request
Storage
Preserve in tight,light-resistant containers in a cool place
Remarks
NA
Custom synthesis
Available
Supply Ability
200kg/month
Company Profile Introduction
Beijing Yibai Biotechnology Co., Ltd features:
1. Management layer's full experience in factory and skilled technicians followers;
2. 10 years experienced exporting sales team;
3. Independent R&D lab;
4. Two signed long term GMP partnership;
5. Rich resources of plenty idle factories for customized project;
6. High Efficiency working team with consistent path.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $35.00/50mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-10-27 | |
| $35.00/50mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-10-27 | |
| $0.00/25KG |
VIP6Y
|
Sichuan Zhuoyu Yantang Technology Co., Ltd.
|
2025-08-26 | |
| $35.00/50mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-04-30 | |
| $/ |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | |
| $0.00/1kg |
VIP1Y
|
Hebei Junhua Import and Export Co., LTD
|
2025-04-07 | |
| $0.00/1kg |
VIP5Y
|
Sinoway Industrial co., ltd.
|
2024-12-26 | |
| $0.00/1g |
HangZhou RunYan Pharma Technology Co.,LTD.
|
2024-11-19 | ||
| $0.00/1KG |
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-10-29 | ||
| $0.00/1g |
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-08-02 |
China- Since: 2018-03-06
- Address: A2011, No.86, Wanxing Road, Changyang, Fangshan District, Beijing, China
INQUIRY